Neuromuscular Blockade: Difference between revisions
No edit summary |
No edit summary |
||
| (27 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Stub Notice}} | {{Stub Notice}} | ||
[https://pubmed.ncbi.nlm.nih.gov/36520073/ 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology 2023;138:13-41] | |||
[https://www.bjaed.org/article/S2058-5349(23)00143-9/fulltext Neuromuscular block management: evidence-based principles and practice] | |||
[https://pubmed.ncbi.nlm.nih.gov/7114542/ Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults.] | |||
[https://pubmed.ncbi.nlm.nih.gov/31584918/ Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children] | [https://pubmed.ncbi.nlm.nih.gov/31584918/ Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children] | ||
| Line 15: | Line 21: | ||
[https://www.bjanaesthesia.org/article/S0007-0912(19)30835-9/fulltext Comparison of incidence of anaphylaxis between sugammadex and neostigmine: a retrospective multicentre observational study] | [https://www.bjanaesthesia.org/article/S0007-0912(19)30835-9/fulltext Comparison of incidence of anaphylaxis between sugammadex and neostigmine: a retrospective multicentre observational study] | ||
[https://pubmed.ncbi.nlm.nih.gov/33543867/ A Survey of the Society for Pediatric Anesthesia on the Use, Monitoring, and Antagonism of Neuromuscular Blockade] | |||
[https://pubmed.ncbi.nlm.nih.gov/28806470/ Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults] | |||
[https://pubmed.ncbi.nlm.nih.gov/29280475/ The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis] | |||
[https://pubmed.ncbi.nlm.nih.gov/30594097/ Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study] | |||
[https://pubmed.ncbi.nlm.nih.gov/26646837/ Sugammadex and rocuronium-induced anaphylaxis] | [https://pubmed.ncbi.nlm.nih.gov/26646837/ Sugammadex and rocuronium-induced anaphylaxis] | ||
| Line 30: | Line 36: | ||
[[Pseudocholinesterase Deficiency]] | [[Pseudocholinesterase Deficiency]] | ||
[https://pubmed.ncbi.nlm.nih.gov/10638896/ Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury] | |||
[https://pubmed.ncbi.nlm.nih.gov/33543867/ A Survey of the Society for Pediatric Anesthesia on the Use, Monitoring, and Antagonism of Neuromuscular Blockade] | |||
[https://pubmed.ncbi.nlm.nih.gov/36520074/ Measuring Success of Patient Safety Initiatives: The 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade] | |||
[https://pubmed.ncbi.nlm.nih.gov/34813652/ Quantitative Neuromuscular Monitoring and Postoperative Outcomes: A Narrative Review] | |||
[https://pubmed.ncbi.nlm.nih.gov/28795964/ Neuromuscular Monitoring in the Perioperative Period] | |||
[https://pubmed.ncbi.nlm.nih.gov/31607388/ Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data] | |||
[https://pubmed.ncbi.nlm.nih.gov/23001053/ Intraoperative neuromuscular monitoring site and residual paralysis] | |||
[https://pubmed.ncbi.nlm.nih.gov/35188958/ Quantitative Neuromuscular Monitoring in Clinical Practice: A Professional Practice Change Initiative] | |||
[https://pubmed.ncbi.nlm.nih.gov/26646837/ Sugammadex and rocuronium-induced anaphylaxis] | |||
[https://pubmed.ncbi.nlm.nih.gov/33329823/ Advantages and pitfalls of clinical application of sugammadex] | |||
[https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/full/10.1002/anr3.12233 Cardiac arrest following sugammadex administration] | |||
[https://pubs.asahq.org/anesthesiology/article/138/2/152/137334/Encapsulation-Dynamics-of-Neuromuscular-Blocking Encapsulation Dynamics of Neuromuscular Blocking Drugs by Sugammadex] | |||
[https://pubmed.ncbi.nlm.nih.gov/9054273/ Intramuscular rocuronium] | |||
[https://pubmed.ncbi.nlm.nih.gov/9366462/ Bioavailability of intramuscular rocuronium in infants and children] | |||
[https://pubmed.ncbi.nlm.nih.gov/10485771/ https://pubmed.ncbi.nlm.nih.gov/10485771/] | |||
[https://pubs.asahq.org/anesthesiology/article/139/1/6/138070/A-Dose-finding-Study-of-Sugammadex-for-Reversal-of A Dose-finding Study of Sugammadex for Reversal of Rocuronium in Cardiac Surgery Patients and Postoperative Monitoring for Recurrent Paralysis] | |||
[https://www.bjanaesthesia.org/article/S0007-0912(23)00385-9/fulltext A retrospective observational cross-sectional study of intraoperative neuromuscular blocking agent choice and dosing in a US paediatric referral hospital before and after introduction of sugammadex] | |||
[https://www.bjanaesthesia.org/article/S0007-0912(23)00104-6/fulltext Pholcodine exposure increases the risk of perioperative anaphylaxis to neuromuscular blocking agents: the ALPHO case-control study] | |||
Suárez Delgado JM, Hernández Soto R, Vilches Martín MJ, Romero RR, Vaz Calderón MA, García Perla JL. Anaesthetic considerations for myelomeningocele in neonates. Paediatr Anaesth. 1998; 8(4): 363-4. PMID: 9672939 | |||
Dierdorf SF, McNiece WL, Rao CC, Wolfe TM, Means LJ. Failure of succinylcholine to alter plasma potassium in children with myelomeningocoele. Anesthesiology. 1986 Feb; 64(2): 272-3. PMID: 3946815 | |||
[https://pubs.asahq.org/anesthesiology/article/139/1/108/138037/Sugammadex-Vial-Wastage-Implications-for-the-Cost Sugammadex Vial Wastage: Implications for the Cost of Anesthesia Care in Children: Research Letter] | |||
[https://pubmed.ncbi.nlm.nih.gov/21149287/ Sugammadex in the management of rocuronium-induced anaphylaxis] | |||
[https://pubmed.ncbi.nlm.nih.gov/35212434/ Role of sugammadex in the treatment of anaphylaxis due to rocuronium in children: Extrapolation from adult and animal reports] | |||
[https://pubmed.ncbi.nlm.nih.gov/22512555/ The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form?] | |||
Analysis of the factors contributing to residual weakness after sugammadex administration in pediatric patients under 2 years of age. Paediatr Anaesth. 2023 Oct 4. doi: 10.1111/pan.14773. Epub ahead of print. PMID: 37792601 | |||
[https://www.bjanaesthesia.org/article/S0007-0912(23)00548-2/fulltext Recurarisation after sugammadex in children: review of case reports and recommendations] | |||
[https://link.springer.com/article/10.2165/00003088-200443020-00001 Antiepileptic-Induced Resistance to Neuromuscular Blockers: Mechanisms and Clinical Significance] | |||
[https://journals.lww.com/anesthesia-analgesia/fulltext/2024/07000/pediatric_intraoperative_electromyographic.7.aspx Pediatric Intraoperative Electromyographic Responses at the Adductor Pollicis and Flexor Hallucis Brevis Muscles: A Prospective, Comparative Analysis] | |||
[https://pubs.asahq.org/anesthesiology/article/141/2/262/141383/Accuracy-and-Precision-of-Three-Acceleromyographs Accuracy and Precision of Three Acceleromyographs, Three Electromyographs, and a Mechanomyograph Measuring the Train-of-four Ratio in the Absence of Neuromuscular Blocking Drugs] | |||
Thilen SR, Sherpa JR, James AM, Cain KC, Treggiari MM, Bhananker SM. Management of Muscle Relaxation With Rocuronium and Reversal With Neostigmine or Sugammadex Guided by Quantitative Neuromuscular Monitoring. Anesth Analg. 2024 Sep 1;139(3):536-544. doi: 10.1213/ANE.0000000000006511. Epub 2023 May 12. PMID: 37171989. | |||
Mason LJ, Betts EK. Leg lift and maximum inspiratory force, clinical signs of neuromuscular blockade reversal in neonates and infants. Anesthesiology. 1980 May;52(5):441-2. doi: 10.1097/00000542-198005000-00015. PMID: 6990835. | |||
[https://pubs.asahq.org/anesthesiology/article/139/1/A16/138250/Goldilocks-and-the-Three-Rocuronium-Reversals-A Goldilocks and the Three Rocuronium Reversals: A Sugammadex Dose-finding Study] | |||
[https://www.bjanaesthesia.org/article/S0007-0912(24)00560-9/fulltext Sugammadex hypersensitivity: a multicentre retrospective analysis of a large Australian cohort] | |||
Revision as of 02:39, 21 November 2024
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
Relevant Article Depot:
Neuromuscular block management: evidence-based principles and practice
Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults.
Encapsulation dynamics of neuromuscular blocking drugs by sugammadex
Neuromuscular blockade in children
Test Your Knowledge: unique advantage of rocuronium
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults
Sugammadex and rocuronium-induced anaphylaxis
Pseudocholinesterase Deficiency
Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury
Quantitative Neuromuscular Monitoring and Postoperative Outcomes: A Narrative Review
Neuromuscular Monitoring in the Perioperative Period
Intraoperative neuromuscular monitoring site and residual paralysis
Sugammadex and rocuronium-induced anaphylaxis
Advantages and pitfalls of clinical application of sugammadex
Cardiac arrest following sugammadex administration
Encapsulation Dynamics of Neuromuscular Blocking Drugs by Sugammadex
Bioavailability of intramuscular rocuronium in infants and children
https://pubmed.ncbi.nlm.nih.gov/10485771/
Suárez Delgado JM, Hernández Soto R, Vilches Martín MJ, Romero RR, Vaz Calderón MA, García Perla JL. Anaesthetic considerations for myelomeningocele in neonates. Paediatr Anaesth. 1998; 8(4): 363-4. PMID: 9672939
Dierdorf SF, McNiece WL, Rao CC, Wolfe TM, Means LJ. Failure of succinylcholine to alter plasma potassium in children with myelomeningocoele. Anesthesiology. 1986 Feb; 64(2): 272-3. PMID: 3946815
Sugammadex Vial Wastage: Implications for the Cost of Anesthesia Care in Children: Research Letter
Sugammadex in the management of rocuronium-induced anaphylaxis
Analysis of the factors contributing to residual weakness after sugammadex administration in pediatric patients under 2 years of age. Paediatr Anaesth. 2023 Oct 4. doi: 10.1111/pan.14773. Epub ahead of print. PMID: 37792601
Recurarisation after sugammadex in children: review of case reports and recommendations
Antiepileptic-Induced Resistance to Neuromuscular Blockers: Mechanisms and Clinical Significance
Thilen SR, Sherpa JR, James AM, Cain KC, Treggiari MM, Bhananker SM. Management of Muscle Relaxation With Rocuronium and Reversal With Neostigmine or Sugammadex Guided by Quantitative Neuromuscular Monitoring. Anesth Analg. 2024 Sep 1;139(3):536-544. doi: 10.1213/ANE.0000000000006511. Epub 2023 May 12. PMID: 37171989.
Mason LJ, Betts EK. Leg lift and maximum inspiratory force, clinical signs of neuromuscular blockade reversal in neonates and infants. Anesthesiology. 1980 May;52(5):441-2. doi: 10.1097/00000542-198005000-00015. PMID: 6990835.
Goldilocks and the Three Rocuronium Reversals: A Sugammadex Dose-finding Study
Sugammadex hypersensitivity: a multicentre retrospective analysis of a large Australian cohort